Bertin Bioreagent

anti-TAF3 (formerly TAFII140), mAb (2F5)

As low as CHF 664.00
In stock
Only %1 left
BRT-G01080-R100100 µlCHF 664.00
NEW
 
More Information
Product Details
Synonyms Transcription Initiation Factor TFIID Subunit 3; TATA-Box Binding Protein-Associated Factor 3; TAFII140; TBP-associated Factor 3
Product Type Monoclonal Antibody
Properties
Clone 2F5
Isotype Mouse IgG1κ
Source/Host Mouse
Immunogen/Antigen Synthetic peptide.
Application ELISA, Western Blot, Immunoprecipitation, Immunocytochemistry. Recommended dilutions: 1/500-1/5000.
Specificity Recognizes human and mouse TAF3.
Formulation Liquid. Does not contain any preservative.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Bertin Bioreagent
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 3 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF
Description
TAF3 is a transcription cofactor and a component of the TFIID complex, which is essential for RNA polymerase II-dependent transcription initiation. It plays an important role in regulating gene expression and transcription initiation. TAF3 is a core subunit of TFIID, a multi-protein complex that recognizes core promoter regions and recruits RNA polymerase II to initiate transcription. TAF3 is involved in the assembly and stabilization of the TFIID complex, ensuring proper interaction between TFIID and other transcription factors. TAF3 participates in chromatin remodeling by recruiting coactivators and chromatin-modifying enzymes. TAF3 is critical for proper gene expression during development, influencing cell differentiation and embryonic growth. Altered expression or mutations in TAF3 may disrupt transcription and contribute to oncogenesis and tumor progression.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.